These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35891202)

  • 41. Design, Synthesis and Primary Immunologic Evaluation of M2e-CRM
    Xu L; Zhang C; Zhang J; Yu R; Su Z
    Curr Pharm Biotechnol; 2021 Oct; 22(14):1910-1918. PubMed ID: 33148152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GMMA-Based Vaccines: The Known and The Unknown.
    Mancini F; Micoli F; Necchi F; Pizza M; Berlanda Scorza F; Rossi O
    Front Immunol; 2021; 12():715393. PubMed ID: 34413858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.
    Berti F; Micoli F
    Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal
    Schager AE; Dominguez-Medina CC; Necchi F; Micoli F; Goh YS; Goodall M; Flores-Langarica A; Bobat S; Cook CNL; Arcuri M; Marini A; King LDW; Morris FC; Anderson G; Toellner KM; Henderson IR; López-Macías C; MacLennan CA; Cunningham AF
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement-mediated serum bactericidal activity of antibodies elicited by the
    Kapulu MC; Nakakana U; Sciré AS; Sarakinou E; Conti V; Rossi O; Acquaviva A; Necchi F; Obiero CW; Martin LB; Bejon P; Njuguna P; Micoli F; Podda A
    Front Immunol; 2022; 13():971866. PubMed ID: 36203568
    [No Abstract]   [Full Text] [Related]  

  • 46. Preclinical validation of an
    Chorro L; Ndreu D; Patel A; Kodali S; Li Z; Keeney D; Dutta K; Sasmal A; Illenberger A; Torres CL; Pan R; Silmon de Monerri NC; Chu L; Simon R; Anderson AS; Donald RGK
    Microbiol Spectr; 2024 Jun; 12(6):e0421323. PubMed ID: 38700324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines.
    Duan H; Huang W; Lv Q; Liu P; Li Q; Kong D; Sun X; Zhang X; Jiang Y; Chen S
    Vaccines (Basel); 2024 May; 12(6):. PubMed ID: 38932301
    [No Abstract]   [Full Text] [Related]  

  • 48. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
    Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
    ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality by Design Framework Applied to GMMA Purification.
    Giannelli C; Necchi F; Palmieri E; Oldrini D; Ricchetti B; Papathanasiou MM; Kis Z; Kontoravdi C; Campa C; Micoli F
    AAPS J; 2024 Mar; 26(2):32. PubMed ID: 38459151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach.
    Necchi F; Carducci M; Pisoni I; Rossi O; Saul A; Rondini S
    J Immunol Methods; 2019 Aug; 471():11-17. PubMed ID: 31039338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigen presentation by Follicular Dendritic cells to cognate B cells is pivotal for Generalised Modules for Membrane Antigens (GMMA) immunogenicity.
    Piccioli D; Alfini R; Monaci V; Arato V; Carducci M; Aruta MG; Rossi O; Necchi F; Anemona A; Bartolini E; Micoli F
    Vaccine; 2022 Oct; 40(44):6305-6314. PubMed ID: 36137901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Towards a Four-Component GMMA-Based Vaccine against
    Micoli F; Nakakana UN; Berlanda Scorza F
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.
    Launay O; Lewis DJM; Anemona A; Loulergue P; Leahy J; Sciré AS; Maugard A; Marchetti E; Zancan S; Huo Z; Rondini S; Marhaba R; Finco O; Martin LB; Auerbach J; Cohen D; Saul A; Gerke C; Podda A
    EBioMedicine; 2017 Aug; 22():164-172. PubMed ID: 28735965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants.
    Rossi O; Pesce I; Giannelli C; Aprea S; Caboni M; Citiulo F; Valentini S; Ferlenghi I; MacLennan CA; D'Oro U; Saul A; Gerke C
    J Biol Chem; 2014 Sep; 289(36):24922-35. PubMed ID: 25023285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against
    Seco BMS; Xu FF; Grafmüller A; Kottari N; Pereira CL; Seeberger PH
    ACS Chem Biol; 2020 Sep; 15(9):2395-2405. PubMed ID: 32835479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23).
    Fairman J; Agarwal P; Barbanel S; Behrens C; Berges A; Burky J; Davey P; Fernsten P; Grainger C; Guo S; Iki S; Iverson M; Kane M; Kapoor N; Marcq O; Migone TS; Sauer P; Wassil J
    Vaccine; 2021 May; 39(23):3197-3206. PubMed ID: 33965258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Novel
    Desalegn G; Kapoor N; Pill-Pepe L; Bautista L; Yin L; Ndungo E; Oaks EV; Fairman J; Pasetti MF
    mSphere; 2023 Jun; 8(3):e0001923. PubMed ID: 37017547
    [No Abstract]   [Full Text] [Related]  

  • 58. Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to ΔVP8* protein from rotavirus.
    Park WJ; Yoon YK; Kim Y; Park JS; Pansuriya R; Cho SN; Seok YJ; Ganapathy R
    Vaccine; 2021 Oct; 39(45):6644-6652. PubMed ID: 34642087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation on Sugar-Protein Connectivity in Salmonella O-Antigen Glycoconjugate Vaccines.
    De Benedetto G; Salvini L; Gotta S; Cescutti P; Micoli F
    Bioconjug Chem; 2018 May; 29(5):1736-1747. PubMed ID: 29697244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Semisynthetic Glycoconjugate Vaccine Candidates against
    Naini A; Bartetzko MP; Sanapala SR; Broecker F; Wirtz V; Lisboa MP; Parameswarappa SG; Knopp D; Przygodda J; Hakelberg M; Pan R; Patel A; Chorro L; Illenberger A; Ponce C; Kodali S; Lypowy J; Anderson AS; Donald RGK; von Bonin A; Pereira CL
    JACS Au; 2022 Sep; 2(9):2135-2151. PubMed ID: 36186572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.